Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CBDW The Role of AI in Investor Relations: A Look Ahead to 2030 https://cbdw.ai/the-role-of-ai-in-investor-relations-a-look-ahead-to-2030/
$CBDW 1606 Corp is transforming e-commerce with CBDWAI, our pioneering AI chatbot technology. With the AI market expected to soar to $2.25 trillion by 2030, investing in 1606 Corp offers a forward-thinking opportunity in the ever-changing digital arena.
Learn more about the latest opportunities to enter the space at the link below:
https://cbdw.ai/
$AGBA News June 12, 2024
AGBA/Triller $4bn Merger: The Group files its Preliminary Proxy Statement
https://finance.yahoo.com/news/agba-triller-4bn-merger-group-122000311.html
$IVDN (16 million float) is about to file a banner quarterly report for its fiscal Q2 which will show that sales of its superior Insultex House Wrap product have already exceeded all of the company's results for the full 2023 fiscal year.
This has been pre-announced in the last two IVDN news releases:
Innovative Designs Sales Update
May 30, 2024
https://finance.yahoo.com/news/innovative-designs-sales-110000236.html
Innovative Designs Vendor Growth
April 10, 2024
https://finance.yahoo.com/news/innovative-designs-vendor-growth-174255528.html
$CBDW price surge!! https://youtube.com/shorts/4-Nkoft-lCk
$CBDW price surge!! https://youtube.com/shorts/4-Nkoft-lCk
In the dynamic landscape of the over-the-counter (OTC) market, 1606 Corp, $CBDW, has captured the attention of investors and market analysts alike. https://cbdw.ai/1606-corp-cbdw-a-promising-breakout/
$FAVO - announces that it has retained the services of Turner, Stone & Company, LLP ("Turner Stone") as its independent auditing firm. Turner Stone is recognized for its expertise in providing comprehensive audit, tax, and advisory services.
https://finance.yahoo.com/news/favo-capital-inc-appoints-turner-171500774.html
$CATV News: Category V Biotech, Inc. Announces Exclusive Licensing of Genetic Networks' Intellectual Property for Cannabis Applications
FLORIDA, July 2, 2024 – Category V Biotech, Inc. (OTC: CATV), formerly known as 4Cable TV International, Inc., is pleased to announce significant progress in our relationship with Genetic Networks, LLC (https://geneticnetworks.com/).
https://www.otcmarkets.com/stock/CATV/news/CATV-signs-Exclusive-Licensing-Deal-with-Genetic-Networks-for-Cannabis-Research?id=445565
$MMMW low float announces today a new product soon and prevents stock dilution.
$AGBA - Together with Triller’s teams, AGBA is expected to drive the Combined Group in three execution focuses:
1. Scaling up to leverage fast-emerging opportunities
2. Developing monetization capabilities
3. Identifying and executing strategic acquisitions and partnerships
https://finance.yahoo.com/news/building-digital-economy-titan-agba-130000244.html
$BSEM The company just released its Q1 EARNINGS which shocked the market. with Revenues tallying up to $41 Million in the first quarter of 2024. The last 6 months have a been a pivotal time for (OTC:BSEM) As the company continues to reach new milestones.
Read https://hugealerts.com/bsem/
$SHOT News: Comedian and Actor Drew "Druski" Desbordes Joins Safety Shot as Their Newest Brand Ambassador
Druski Joins the Company's Impressive Portfolio of Creators and Celebrities to Boost Awareness of the Revolutionary Beverage with a Wide Range of Consumers
JUPITER, Fla., June 27, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) proudly announced today a partnership with American comedian and actor, Drew "Druski" Desbordes, as a brand ambassador.
Druski, most well known for his sketch-style comedy, entertains and embraces his 7.7 million followers on Instagram and 6.8 million on TikTok. He's collaborated with various musicians and appeared in music videos for artists including Jack Harlow, Drake, Lil Yachty, and more. Druski has done four nationwide tours in the U.S. and headlined his first comedy tour, "Coulda Woulda Shoulda", in March 2023. He's appeared in movies and television shows such as House Party and Grownish and is executive producing several TV & film productions for release in 2024. With a loyal fanbase and an aptitude for creating shareable content, Druski makes the perfect partner for Safety Shot.
Safety Shot is a first-of-its-kind functional beverage crafted with Essential B vitamins, antioxidants, electrolytes, and nootropics designed to rapidly rehydrate, and boost mental clarity, energy, and overall mood. Disrupting the industry and creating a category of one, Safety Shot is the world's first beverage to reduce blood alcohol content by supporting its metabolism in as little as 30 minutes. Druski's unique blend of authenticity and entertainment resonates strongly with his fan base, an attribute that the Company believes will translate well with their consumer. The Company aims to utilize the partnership with Druski to amplify brand awareness to a wider audience, leveraging his widespread appeal, vibrant energy, and creative content to enhance Safety Shot's visibility, drive virality, and build upon consumer interest and loyalty.
"We're so thrilled to welcome Druski as a Safety Shot brand ambassador," said Safety Shot Chief Revenue Officer Josh Wagner. "Druski's humor and relatable content have garnered him a massive following across social platforms. His ability to connect with a wide-ranging audience through his comedic talent and engaging personality makes him an ideal ambassador for Safety Shot. We're happy to welcome Druski to the team and we're excited for the partnership."
Other ambassadors to the brand include widely followed Youtube and social media personalities The Nelk Boys, Ryan Garcia, Matthew Espinosa, professional skateboarder Danny Way and more.
For more information, visit http://www.drinksafetyshot.com.
About Safety Shot, Inc
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
https://c212.net/c/img/favicon.png?sn=LA49778&sd=2024-06-27 View original content to download multimedia:https://www.prnewswire.com/news-releases/comedian-and-actor-drew-druski-desbordes-joins-safety-shot-as-their-newest-brand-ambassador-302183923.html
SOURCE Safety Shot
Metatron Apps ( $MRNJ ) Be sure to try out our new Free AI girlfriend app! bit.ly/MyAIGirlfriend
Metatron Apps ($MRNJ) Be sure to try out our new Free AI girlfriend app! https://t.co/gabN74ohtD pic.twitter.com/TKxIw9F5pr
— MetatronAI.com $MRNJ (@MetatronInc) June 10, 2024
$MMA soars another 10% and up 25% in 2-session. Looks like momentum could be continued and we may see 3.60-3.80.
BIG NEWS - Yesterday, the company partnered with Two-Time Strikeforce Champion and Former UFC Fighter Gilbert Melendez. This could lead the company to targeting 45,000 potential combat sports gym partners in the US.
$CRDL is all set for virtual Annual General and Special Meeting of Shareholders (the "AGM") will be webcast on June 26, 2024, at 4:30 p.m. EDT.
https://finance.yahoo.com/news/cardiol-therapeutics-webcast-virtual-annual-112700000.html
The stock has gained 18% from recent low of $1.80. The stock us already up 140% so far this year. Going forward, the stock may fill the gap to its next hurdle of $2.40.
$MMA stock had a stable move yesterday and soared about 14% n unusual volumes. The stock is now trading above the key hurdle and may fill the gap to $3.60-3.90.
BIG NEWS - Yesterday, the company partnered with Two-Time Strikeforce Champion and Former UFC Fighter Gilbert Melendez. This could lead the company to targeting 45,000 potential combat sports gym partners in the US.
$TNXP gains momentum after presenting vaccine platform data at the Vaccine Congress 2024. The stock is due for a massive short squeeze and it could be right time. The stock may fill the gap to $1.65-1.75.
Here are key highlights from today’s news:-
TNX-801 vaccination demonstrated efficacy in protecting animals from lethal challenge with intratracheal monkeypox
Clade II mpox is now endemic in the U.S. with >30,000 cases reported since May 20221 and Clade I mpox is endemic in the Democratic Republic of the Congo2
Tonix’s vaccine platform has been selected by NIH’s Project NextGen for clinical testing
$SHOT News: Safety Shot Announces Strategic Partnership with Chip Quigley and Ari Freedman
The Executives Will Support the Company with Deep Expertise Across Entertainment, Development and Distribution
JUPITER, Fla., June 25, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) proudly announces today a strategic partnership with Chip Quigley, founder and CEO of Kingdom Entertainment Group, and Ari Freedman, a seasoned executive from Surge Brands, to advise across the brand's marketing and events, and brand development and distribution respectively.
Quigley brings over two decades of experience in the New York concert business, artist management space, and has extensive involvement in producing high-profile events including the Jones Beach Concert Series, EP of the International Emmy Awards, The Victoria Secret TV specials and more. Known for crafting cutting-edge marketing campaigns and activations for brands across multiple consumer categories, Quigley's background and overarching strategic vision for Safety Shot will be invaluable in elevating the Company through innovative events and promotional initiatives.
Freedman has successfully led countless brands to achieve significant growth and market penetration through development and distribution, and brings to the table a keen eye for market trends and consumer behavior. His expertise will play a crucial part in expanding Safety Shot's distribution channels and ensuring that the product reaches a wider audience.
"We are thrilled to partner with Chip and Ari to tap their expertise to further elevate Safety Shot's market presence through high-profile events and marketing campaigns as well as a strategic oversight on distribution," said Josh Wagner, Chief Revenue Officer of Safety Shot. "Their years of combined experience offer a fresh lens on the brand and bring new perspectives and growth opportunities, ultimately fast-tracking our goal to disrupt the industry with our first-of-its-kind beverage."
This announcement comes on the heels of Safety Shot's Northeast expansion plan and partnership with Mr. Checkout and Capital Drugs pharmacies across the United States. Additional partnerships include GoPuff, BevMo, and more.
For more information, visit www.drinksafetyshot.com.
About Safety Shot, Inc
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
https://c212.net/c/img/favicon.png?sn=LA47370&sd=2024-06-25 View original content to download multimedia:https://www.prnewswire.com/news-releases/safety-shot-announces-strategic-partnership-with-chip-quigley-and-ari-freedman-302181122.html
SOURCE Safety Shot
$GRLF News: Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai
Pembroke Pines, FL -- June 24, 2024 -- InvestorsHub NewsWire -- Green Leaf Innovations, Inc. (OTCPK: GRLF), an emerging growth company specializing in marketing and distributing handmade premium cigars, announces a major expansion in its international distributor partnerships with Le Cigaro FZ-LLC in Dubai and the UAE. Le Cigaro has selected the Cubanacan Heritage Cigar Brand under the Green Leaf Innovations umbrella as one of its signature offerings for its esteemed clientele.
Le Cigaro is renowned as the premier destination for cigar enthusiasts, offering a wide range of cigars, accessories, and wine accessories. They provide custom-made humidor cabinets with built-in humidifiers to preserve cigar quality, along with expert-led cigar training sessions.
Additionally, Le Cigaro enhances the cigar experience with personalized drink pairing recommendations and hosts live cigar rolling events for private gatherings. Their exclusive cigar agreement includes renowned hotel chains such as:
W Hotel W ABU DHABI - YAS ISLAND which caters to the FORMULA 1 ETIHAD AIRWAYS ABU DHABI GRAND PRIX 2024.
Abu Dhabi National Hotels, a chain of 16 hotels known for their exceptional hospitality.
Bvlgari Hotels & Resorts, renowned for their luxury and elegance.
The Ritz-Carlton, Dubai (ritzcarlton.com), a symbol of sophistication and luxury.
Crown Plaza Hotels, offering a blend of comfort and class.
"We are delighted that Le Cigaro has chosen our Cubanacan Heritage Cigar Brand," said Robert Mederos, CEO of Green Leaf Innovations. "This partnership and Le Cigaro's exclusive hotel agreements underscore our commitment to expanding globally and delivering premium cigar experiences in Dubai and the UAE."
About Le Cigaro FZ-LLC
Le Cigaro FZ-LLC is a premier wholesaler of cigars, cigar accessories, and wine accessories in Dubai and the UAE. Known for its exceptional range of products and services, Le Cigaro is dedicated to enhancing the cigar experience for its prestigious clients. From custom-made humidor cabinets to cigar training and live cigar rolling events, Le Cigaro provides a comprehensive and memorable cigar experience.
For more information about Le Cigaro FZ-LLC please visit www.lecigaro.com
About Green Leaf Innovations, Inc.
Green Leaf Innovations, Inc., a Florida corporation, is an emerging growth company engaged in the Marketing and Distribution of handmade premium cigars. The company strategically imports and exclusively distributes some of the best-known premium cigar brands in the Market created by the Mederos family a Third generation Cigar maker with Robert Mederos at the helm who has owned and operated handmade cigar operation in Nicaragua and the US for over 20 years with a rich family history in the craft dating back to the 1800s Cuba, brands such as CUBANACAN, MEDEROS and TABACALERA SERRANO. In addition to it the company also distributes packaged whole leaf Tobacco to cigar lounges, smoke shops, C-stores and vape shops across the United States and soon International Markets.
Additional information can be found on our websites http://www.greenleafinnovation.com or follow us on Twitter @otcgrlf.
Phone number: (800) 303-6268
Email: info@greenleafinnovation.com
Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. The Company may also make written or oral forward-looking statements in its filings with the U.S. Securities and Exchange Commission, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. There can be no assurance that such statements will prove to be accurate. The Company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the Company's Annual Reports on Form 10-K and its other filings with the Securities and Exchange Commission. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control. The Company does not undertake any obligation to update publicly or to revise any statements in this release, whether as a result of new information, future events, or otherwise.
$PRSO Ladenburg analyst Jon Hickman initiated coverage of Peraso with a Buy rating and $3.75 price target.
https://www.tipranks.com/news/the-fly/peraso-initiated-with-a-buy-at-ladenburg?mod=mw_quote_news
$AXIL is one of the interesting consumer product companies I have shortlisted. It is a manufacturer and marketer of premium hearing enhancement and protection products under the AXIL® brand and premium hair and skincare products, selling in the United States, Canada, and the European Union.
What’s catching my eye is the company’s exclusive sponsorship of the USA shooting team. It’s a 5-year partnership and would help the company grow. The partnership grants AXIL co-branding privileges on USA Shooting’s digital channels, promotional materials at events, and signage at national competitions until 2028.
https://www.nasdaq.com/press-release/athleisure-and-luxury-fuse-lead-consumer-trends-2024-06-24
$MMA - Alta Global Group Ltd (NYSEAMERICAN: MMA) stock could see a quick bounce anytime. The stock has been falling on a very low volume – signaling weak hands are almost out. Smart people must be still holding for the company’s growth. Now at $2.64, with a solid support at $2.4-2.50, it has potential to fill the gap to $3.70-3.80.
$FAVO - The partnership aims to enhance FAVO's capital structure, uplist to a major exchange, explore potential acquisitions, and drive overall growth.
https://finance.yahoo.com/news/favo-capital-engages-investment-bank-114500969.html
$MMA Alta Global Group (NYSE American:MMA) announced its strategic acquisition of Hype for. Hype is a subscription-based mobile marketing platform designed to help small businesses grow in today's age of social media.
Hype's software platform strengthens Alta's vision to convert 640 million MMA fans to participants by providing invaluable tools.
Hype has processed over $40 million in payments through its platform, collected over 4 million contacts for current and previous customers, and generates revenue from recurring subscriptions and payment processing fees.
$TNXP soared another 11% on Thursday on hefty volume and closed at a HOD. The company made impressive progress on TonmyaTM and announced a positive pre-NDA CMC meeting with the FDA. Excitement is building as the company anticipates the official minutes, which might indicate substantial progress towards bringing the drug to market.
No doubt, this is big news and could trigger a short squeeze.
Also, in the second half, it is planning submit the NDA for Tonmya to the FDA.
$BDCC News June 18, 2024
Blackwell 3D Corporation Secures Services of Prominent Civil Engineer & Construction Entrepeneur as Key Consultant, Finalizing Design of 3D Printer
https://finance.yahoo.com/news/blackwell-3d-corporation-secures-services-040533630.html
$SPTY Specificity Inc. Acquires livePRO: A Strategic Move to Revolutionize Real-Time Customer Interaction
https://finance.yahoo.com/news/specificity-inc-acquires-livepro-strategic-153000500.html
$CCTG News: CCSC Technology International Holdings Limited Enters into International Purchase Agreement with SHI / LIGHTCARE-SOLUTIONS ApS
Hong Kong, June 20, 2024 (GLOBE NEWSWIRE) -- CCSC Technology International Holdings Limited (the “Company” or “CCSC”) (Nasdaq: CCTG), a Hong Kong-based company that engages in the sale, design and manufacturing of interconnect products, including connectors, cables and wire harnesses, today announced that it has entered into an international purchase agreement (the “Agreement”) with SHI / LIGHTCARE-SOLUTIONS ApS (“SHI”), a Danish company that primarily engages in the design and supply of healthcare lighting products.
Pursuant to the Agreement, CCSC will manufacture and supply healthcare lighting products based on the designs provided by SHI to customers in the Asia Pacific region. Under this Agreement, the parties estimate that the annual purchasing amount will start at €0.50 million (approximately US$0.54 million) in 2025 and increase to €3.50 million (approximately US$3.76 million) in 2030.
Mr. Kung Lok Chiu, Chief Executive Officer and Director of the Company, commented, “We are thrilled to partner with SHI to expand our healthcare lighting business in the Asia Pacific market. This partnership aligns with our strategic goal of diversifying our product portfolio and expanding our presence in the healthcare sector. Through our collaboration with SHI, we are poised to deliver innovative and effective lighting solutions that meet the needs of customers in the healthcare industry. We believe this collaboration will drive growth for both companies in the foreseeable future.”
About CCSC Technology International Holdings Limited
CCSC Technology International Holdings Limited, is a Hong Kong-based company that engages in the sale, design and manufacturing of interconnect products. The Company specializes in customized interconnect products, including connectors, cables and wire harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. The Company produces both OEM (“original equipment manufacturer”) and ODM (“original design manufacture”) interconnect products for manufacturing companies that produce end products, as well as electronic manufacturing services (“EMS”) companies that procure and assemble products on behalf of such manufacturing companies. The Company has a diversified global customer base located in more than 25 countries throughout Asia, Europe and the Americas. For more information, please visit the Company’s website: http://ir.ccsc-interconnect.com.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company's proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “may,” “will,” “could,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “propose,” “potential,” “continue”, or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the U.S. Securities and Exchange Commission.
For more information, please contact:
CCSC Technology International Holdings Limited
Investor Relations Department
Email: ir@ccsc-interconnect.com
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
https://www.globenewswire.com/newsroom/ti?nf=OTE1NTg4NSM2MzIzMTcxIzUwMDEyMTQ3OQ==
https://ml.globenewswire.com/media/MGFmNWE3ZTUtNmNlNS00MzUwLTg2ZTAtOTNhYjhkNDM3NWE1LTUwMDEyMTQ3OQ==/tiny/CCSC-Technology-International-.png
Source: CCSC Technology International Holdings Limited
$MMA stock has been falling on a very low volume. It’s a matter of time, the stock forms the bottom at around $2.50 (Major support), and starts moving higher.
Noticeably, Alta Global Group (NYSE American:MMA) has partnered with Australian former UFC fighter Jessica-Rose Clark – this would strengthen its connection with the global MMA community, encouraging fans to actively participate in martial arts.
$NRXP News: NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors
Dr. Dennis McBride brings extensive experience in Neuroscience and its interface with Information and Medical Technology
Retired at a rank that is the civilian equivalent of a senior flag officer from the United States Navy
RADNOR, Pa., June 18, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that the Company has added Dr. Dennis McBride to its Board of Directors. Dr. McBride brings deep experience in Neuroscience, Medical and Information Technology and digital therapeutics to the Company.
"I am delighted to welcome Dennis to the Board of NRx. His unique background in both Neuroscience and Medical Technology will be an important asset to the company as we seek to develop more advanced treatments for patients," said Dr. Jonathan Javitt, Chairman and Chief Scientist of NRx. "I have worked with Dennis previously on a highly successful digital therapeutic and know the quality he brings to our company."
"I am proud to join the Board of NRx at such an exciting time for the company – the opportunities have never been greater in Neuroscience to advance and improve novel therapies," commented Dr. McBride. "I look forward to using my experience to help advance its strategy and further the development of NRx's impressive pipeline of CNS products and leading its initiative in digital therapeutics."
Dr. Dennis McBride has led numerous national and international initiatives in neuroscience and its interface with information technology, national security, and medical technology/drug development both within the federal government and in the private sector, three of which are now multi-billion-dollar enterprises. He has formative experience in CNS-focused digital therapeutics, having participated with NRx founders in developing now military-proven digital therapeutic technology for reduction of stress and depression. He was instrumental to the founding of InQTel and other private sector-focused initiatives.
Dr. McBride dedicated his Navy career to Aerospace Medicine and ergonomics, during which he served in leadership roles at six nationally-prominent laboratories, including the Defense Advanced Research Projects Agency (DARPA), Naval Aerospace Medical Research Lab, Naval Research Lab, the Office of Naval Research, and the Naval Medical Research Institute. Upon retiring as a highly decorated Navy Captain, he assumed leadership of the Potomac Institute for Policy Studies, where he continues to serve as President Emeritus. He then joined the National Defense University as a Professor to lead the Center for Technology and National Security Policy, completing his term as a Senior Executive-4 (Civilian equivalent to Vice Admiral). Most recently, he served a tour of duty in the Office of the Secretary of Defense. Dr. McBride has served as an adviser to Cabinet Secretaries, US Congressional Committees, and to corporate C-Suite executives. His educational background includes the University of Georgia, Naval Aerospace Medical Institute, the University of Southern California, the London School of Economics, and Harvard Business School, earning a Ph.D. in experimental psychology and four master's degrees.
About NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx has partnered with Alvogen and Lotus around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently announced plans to submit a New Drug Application for HTX-100 (IV ketamine), through Hope Therapeutics, in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
About HOPE Therapeutics, Inc.
HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a Specialty Pharmaceutical Company, wholly-owned by NRX Pharmaceuticals focused on development and marketing of an FDA-approved form of intravenous ketamine for the treatment of acute suicidality and depression together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.
Notice Regarding Forward-Looking Statements
The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.
https://c212.net/c/img/favicon.png?sn=CL42013&sd=2024-06-18 View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-appoints-neuroscience-information-technology-and-medical-technology-veteran-to-its-board-of-directors-302175147.html
SOURCE NRx Pharmaceuticals, Inc.
$MMA stock has formed a nice based around $3 and once the volume picks up, it could see a nice rally towards $4.50. Just need some patience. Last week, Alta Global Group (NYSE American:MMA) had big news and partnered with Australian former UFC fighter Jessica-Rose Clark. By partnering with an esteemed and popular figure like Jessica-Rose Clark, Alta aims to strengthen its connection with the global MMA community, encouraging fans to actively participate in martial arts.
$AIMD today announced critical progress in the clinical trials of its revolutionary "Ainos Flora" volatile organic compound ("VOC") POCT device that is based upon its transformative AI-powered digital nose ("AI Nose") technology. https://www.accesswire.com/877292/ainos-unveils-critical-progress-in-ainos-flora-clinical-trials-and-next-gen-plans-powered-by-nvidia-cuda
$RENB News: Renovaro, Inc. Announces $10 million in Equity Committed
LOS ANGELES, June 14, 2024 (GLOBE NEWSWIRE) -- Renovaro, Inc. (NASDAQ: RENB) (the “Company”) announces that it has $10 million in additional equity committed at a price per share of $1.4726 and 10 percent warrant coverage.
“We appreciate confidence in the Company demonstrated by the investors,” said the Hon. Mark Dybul, MD, CEO. “We believe this is only the beginning. We are hopeful to be able to secure additional financing such as, but not limited to, long-term loans, grants and subsidies from various US and European institutions for which the Company is eligible – potentially worth tens of millions of dollars.”
Forward-Looking Statements
Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline and platform. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.
For media inquiries, please contact: karen@renovarocube.com
Source: Renovaro Inc.
$FAVO - announces that it has retained the services of Turner, Stone & Company, LLP ("Turner Stone") as its independent auditing firm. Turner Stone is recognized for its expertise in providing comprehensive audit, tax, and advisory services.
https://finance.yahoo.com/news/favo-capital-inc-appoints-turner-171500774.html
$FAVO - Glen is the Founder and Chairman of Stewards Investment Capital, a significant shareholder in FAVO Capital, Inc. He has an extensive background as a Director and Board Member of various companies within the financial industry.
https://finance.yahoo.com/news/favo-capital-inc-welcomes-glen-142000952.html
#favocapital @favocap
$CYCA News: CyttaAIR Partners with FIZUAS to Dominate the American Drone Reseller and Advanced Streaming Technology Market
Massive Florida Demand for CyttaCOMMS and Drones Drives Partnership
LAS VEGAS, NV / ACCESSWIRE / June 13, 2024 / Cytta Corp (OTCQB:CYCA), a leading provider of innovative technology solutions for public safety and cybersecurity industries, is excited to announce that CyttaAIR, in an expansion of its longstanding reseller partnership with FIZUAS Unmanned Aircraft Systems, a premier national drone reseller, is now entering the drone reseller market. This strategic joint venture aims to meet the growing demand for American-made drones, particularly from law enforcement agencies transitioning away from foreign drones.
A Strategic Move in Response to Growing Demand
This expanded partnership with FIZUAS comes at a critical time when numerous law enforcement agencies in Florida are seeking guidance on which drone brands and models to purchase. This transition to American-made drones is driven by legislative changes and a heightened focus on data security. Through this joint venture, CyttaAIR will provide these agencies with top-tier, compliant drone options, enhancing their operational capabilities and ensuring adherence to new regulations.
Quote from Mike Elliott, VP of Business Development
"We are thrilled to be partnering with a premiere national drone reseller like FIZUAS," said Mike Elliott, VP of Business Development at Cytta Corp. "The number of law enforcement agencies in Florida asking about which drone brands and models to purchase has skyrocketed. This joint venture allows CyttaAIR to expand into this rapidly growing market, providing our clients with the best in American-made drone technology and our leading CyttaCOMMS secure video streaming solution."
Expanding CyttaAIR's Reach
This collaboration is poised to position CyttaAIR as a dominant player in the drone reseller market. By leveraging FIZUAS's extensive reseller network and expertise, CyttaAIR/FIZUAS will jointly offer a comprehensive range of drones equipped with the secure and collaborative capabilities of CyttaCOMMS. This move underscores Cytta Corp.'s commitment to providing cutting-edge technology solutions that meet the evolving needs of law enforcement and other critical sectors.
About Cytta Corp:
Cytta Corp. is a leading technology solutions provider dedicated to delivering innovative products and services across various industries and revolutionizes the integration, streaming, transfer, and storage of video and audio data. With a focus on safety, security, and efficiency, Cytta Corp strives to develop cutting-edge solutions that address real-world challenges in large markets.
The Company's proprietary CyttaCOMMS incident management system offers real-time integration of video and audio streams, enabling improved collaboration and providing ongoing, relevant, actionable intelligence. Their innovative new product, CyttaCARES , is a game-changer in ensuring the safety and well-being of children in educational institutions and beyond. CyttaAIR, a groundbreaking platform designed to innovate and consolidate the best of drone hardware, software, and resources for Federal and State Law Enforcement Agencies. Cytta's CyttaCOMP ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) technology delivers real-time compression of video streams with ultra-low latency.
About FIZUAS Unmanned Aircraft Systems
FIZUAS is a leading national drone reseller known for providing high-quality, reliable drone solutions to various industries. Their extensive network and extensive first responder and industry expertise make them a trusted partner for organizations looking to integrate drone technology into their operations.
Contact Information
Investor/Shareholder Contact:
Gary Zwetchkenbaum
PlumTree Consulting, LLC.
gzplumtree@gmail.com
Direct: (516)-455-7662
Cytta Corp.
Toll free #: 1 877 CYTTAUS (298 8287)
Call Local: 1 740 CYTTAUS (298 8287)
http://www.cytta.com
info@cytta.com
Gary Campbell, CEO
Direct (702) 900-7022 (or message)
Gary@cytta.com
Mike Elliott, VP of Business Development
mikeelliott@cytta.com
(689) 222-8708
SOURCE: Cytta Corp.
$RENB: Impressive Short Squeeze Triggered for Cancer Immunotherapy Company Renovaro, Inc. (NASDAQ: RENB)
https://markets.financialcontent.com/startribune/article/getnews-2024-6-10-impressive-short-squeeze-triggered-for-cancer-immunotherapy-company-renovaro-inc-nasdaq-renb
$NRXP News: NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter
The June 2024 meeting of the American Society for Clinical Psychopharmacology (ASCP) focused heavily on increasing use of intravenous ketamine and intranasal S-ketamine as the emerging standard of care for treating severe depression and suicidality
Presenters from 3 open label studies at the ASCP suggested that intravenous ketamine is at least equivalent and may have advantages over intranasal S-ketamine
NRx Pharmaceuticals has now reached the 9-month stability point with its ketamine formulation (NRX-100) and has initiated 3 manufacturing lots for future drug release. Nonclinical safety for short term use of NRX-100 has recently been published and submitted to FDA
FDA leadership, in public comments at ASCP, focused on the need for nonclinical safety data for intravenous ketamine as a condition of ketamine approval
The short-term need for intravenous ketamine as an already-approved, schedule 3 drug, is heightened by recent regulatory decisions that may delay the path of potent, schedule 1 psychedelic drugs that may require more complicated clinical trial designs.
RADNOR, Pa., June 10, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that the Company posted a new Shareholder Update Letter on its website NRx Shareholder Update and further invites interested parties to subscribe to their email alert service to stay up to date on company's progress here: NRx Email Alerts . (Note: not all updates will be included in a Press Release in the future).
Today's update highlights potential implications of the Company's recent activities at the annual meeting of the American Society of Clinical Psychopharmacology. The key points include:
Intravenous and intranasal ketamine were highlighted as emerging standards of care for severe depression and suicidality
Planned NDA filing for NRX-100, our preservative free IV ketamine, for Suicidal Depression in 2024, is based on well controlled trials against both placebo and active comparator. Fast Track Designation was previously granted
An independent FDA advisory panel recently voted against MDMA, a potent, class I psychedelic, refocusing attention on already-approved Schedule 3 drugs such as ketamine for treatment of suicidal depression. The FDA panel and emerging guidance highlights the complexity of clinical trials of DEA Schedule 1 hallucinogens that do not have already-approved human uses
NRx anticipates that an important issue for longer term use of ketamine in depression will be the current multidose vial presentation that contains potentially toxic preservatives previously acceptable for one time use but less suitable for repeated use. NRX-100 is planned as a single-dose, preservative-free medication.
Please subscribe to the Company's email for future updates. NRX Email Alerts Not all of these will be the subject of a Press Release in the future.
About NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx has partnered with Alvogen and Lotus around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently announced plans to submit a New Drug Application for NRX-100 (IV ketamine), in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
About HOPE Therapeutics, Inc.
HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a Specialty Pharmaceutical Company, wholly-owned by NRX Pharmaceuticals, focused on development and marketing of an FDA-approved form of intravenous ketamine for the treatment of acute suicidality and depression, together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.
Notice Regarding Forward-Looking Statements
The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.
https://c212.net/c/img/favicon.png?sn=CL35448&sd=2024-06-10 View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-publishes-shareholder-update-letter-302168228.html
SOURCE NRx Pharmaceuticals, Inc.
$RJDG RJD Green Inc.'s Silex Holdings Division Has Record Breaking Revenue in May
https://www.newmediawire.com/news/rjd-green-inc-s-silex-holdings-division-has-record-breaking-revenue-in-may-7075516
$GV News: Broader Development Opportunities for PSW Sector
TORONTO, June 7, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced the cooperation with Canadian International Career College (CICC) will have broader development opportunities.
On June 3, 2024 the Honourable Marc Miller, Minister of Immigration, Refugees and Citizenship announced two pilot programs that allow caregivers to directly obtain PR status upon arrival in Canada.
The new pilot programs require caregivers to have a full-time job offer for a home care position, relevant work experience, a language proficiency of CLB (Canadian Language Benchmarks) level 4, and an education level equivalent to a Canadian high school diploma. These new pilot programs expedite the immigration process for caregivers coming to Canada to care for children, the elderly, and people with disabilities. Caregivers can also work for organizations that provide temporary or part-time care services to individuals who are semi-independent or recovering from injuries. This new pathway means that caregivers can more easily find employers.
This news is extremely beneficial for the PSW (Personal Support Worker) industry. the Company's subordinate Farvision Career Education Group Inc signed a cooperation agreement with Canadian International Career College to explore the market in Asia on May 9,2024. We believe with the implementation of the two pilot programs in Canada, we will have more support for our development in the Asian market. The company will expedite its efforts to develop the Asian market.
The Canadian International Career College (CICC) provides Personal Support Worker Certificate, Medication Administration for PSW Certificate Course, Early Childcare Assistant (ECA) Diploma Course, Intensive Care Unit (ICU) Program for Nurse Certificate Course, Medical Surgical Certificate Course, CPR/AED Certificate Course, Standard First Aid with CPR Course, and Business Programs.
About Visionary Holdings Inc.
Visionary Holdings Inc. headquartered in Toronto, Canada, is a private education provider located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The Company aims to provide access to secondary, college, undergraduate and graduate and vocational education to students in Canada through technological innovation so that more people can learn, grow and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the Company has been serving and will continue to serve both Canadian and international students. For more information, visit the Company's website at https://ir.visiongroupca.com/.
Forward-Looking Statements
All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "believes," "expects," "anticipates," "estimates," "intends," "would," "continue," "should," "may," or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and in its other filings with the SEC.
For more information, please contact:
Visionary Holdings Inc.
Investor Relations Department
Email: ir@farvision.ca
https://c212.net/c/img/favicon.png?sn=CN34236&sd=2024-06-07 View original content:https://www.prnewswire.com/news-releases/broader-development-opportunities-for-psw-sector-302167022.html
SOURCE Visionary Holdings Inc.
$OCX Last week, Oncocyte announced positive data results for its flagship diagnostic product, VitaGraft™.
In a phase 2 double-blind, placebo-controlled study (NCT05021484), VitaGraft Kidney was used to monitor graft injury associated with the investigational drug felzartamab, a fully human CD38 monoclonal antibody, aimed at treating antibody-mediated rejection (AMR), a leading cause of kidney allograft failure.
VitaGraft Kidney assesses the health of grafts by measuring the amount of donor-derived DNA in the blood of transplant patients, serving as a crucial biomarker.
$MMA - Alta Global Group (NYSE American:MMA) announces significant partnership with legendary MMA coach Eric Nicksick, renowned for guiding three fighters to UFC championships, including Francis Ngannou, Aljamain Sterling, and Sean Strickland.
This big announcement is set to deepen Alta's connection with MMA's 640 million fans and convert fandom into active participation.
Alta estimates each active gym partnership could produce an average of $88,000 in annual revenue for the Company if they run two Alta Programs each year (average 24 participants per program) and cross-sell the Alta Pass, Academy products and Hype, Alta's all-in-one digital marketing platform for small business.
Alta has over 500 active gym partnerships and is targeting approximately 45,000 potential combat sports gym partners in the US as it expands its network globally.
$MMA Based on the technical chart, the risk-reward ratio is surely in buyers favor. The stock has been consolidating near $4, and it’s just a matter of time, we could see it flying above $5. Just need some patience!!
$CRDL – Get ready for the biggest catalyst soon. The company may release FDA decision for Pericarditis Ph2 trial! It may hit the market next week.
Considering the rise of 180% this year, the stock looks good and if we get positive outcome, the stock may be ready to fly big. Analysts are already very bullish on the stock with PT of $8. So biotech traders must keep $CRDL on their radar.
$RWGI is proud to announce a significant strategic move including signing a Letter of Intent (LOI) for the dispensary's license acquisition, further solidifying RWGI's presence in the burgeoning cannabis market. https://finance.yahoo.com/news/rodedawg-otc-rwgi-expands-dispensary-120000919.html
$CBDW is pleased to invite investors to a webinar on June 11, 2024, at 4:15 p.m. ET. https://finance.yahoo.com/news/rodedawg-otc-rwgi-expands-dispensary-120000919.html
$FAVO - An experienced professional with over 25 years in the financial and investment industry, Glen brings specialized skills, in-depth expertise and strategic insight, further strengthening the exceptional leadership team at FAVO.
https://finance.yahoo.com/news/favo-capital-inc-welcomes-glen-142000952.html
#favocapital @favocap
$GTVH News: Golden Triangle Ventures Announces Strategic Stock Buyback Initiative
LAS VEGAS, June 06, 2024 (GLOBE NEWSWIRE) -- via IBN -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) is thrilled to announce a strategic initiative aimed at significantly enhancing shareholder value. The Company recently announced that it has completed the acquisition of Cargo Management Group, a multifaceted logistics and trucking operation. Through this initial acquisition, management has agreed to use 10% of the profits from its logistics business to buy back and retire GTVH stock, effectively reducing the amount of outstanding shares on a consistent basis as profits are realized. This action highlights GTV’s commitment to driving long-term value for its shareholders.
Cargo Management Group achieved nearly $3 million in revenue for 2023 through its portfolio of contracts with industry leaders such as JB Hunt, CH Robinson, Coyote Logistics, and Echo Logistics. Management is actively pursuing relocating its headquarters to a new and upgraded operations facility. This action is anticipated to streamline internal operations, yield significant cost savings, and bolster cash flow, with a focus on enhancing the Company’s business margins. Furthermore, the Company is poised to grow its profits through strategic initiatives such as expanding its client base, optimizing route efficiency, and implementing innovative technologies to increase operational effectiveness and profitability.
To execute a compliant, effective and efficient stock buyback, the Company is engaging legal and financial counsel. This collaboration ensures that the buyback process adheres to all regulations, and it will officially commence once the full transition of the logistics business is complete and profits of the business can be realized. Furthermore, this strategic initiative demonstrates the Company’s commitment to optimizing capital allocation by reinvesting earnings into growth and stability. By taking this meticulous approach, the Company aims to enhance long-term shareholder value while maintaining regulatory compliance and operational efficiency.
Marco Antonio Moreno, president and COO of Lavish Entertainment, states, “We are confident about successfully implementing our initiatives, maintaining profitability and significantly scaling the operation. Our goal is to secure premium, dedicated, high-paying lanes, upgrade our existing equipment, strengthen all operations, and expand our business into more lucrative markets, which further supports our other internal projects. This transition marks a pivotal moment in our journey, as we are now boots on the ground working towards a seamless integration, transition and a complete business enhancement on all fronts.”
Steffan Dalsgaard, president of Golden Triangle Ventures, states, “This initiative marks the first of several strategies we plan to implement that aim to optimize our capital structure within GTV. Our goal is to develop true fundamental business activities that support all of our operations. We have successfully implemented the first part of our four-pillar business model that supports Lavish Entertainment and our flagship Destino Ranch project, and our team is now focused on executing a series of other promising developments. These efforts are designed to further our objective of increasing shareholder value across all facets of our company.”
About Cargo Management Group: http://www.CargoManagementGroup.com
About Golden Triangle Ventures, Inc.
Golden Triangle Ventures, Inc. or “GTV” is a multifaceted consulting Company, which operates as the parent business pursuing ventures in the health, entertainment and technology sectors, along with others that provide synergistic value to these three core divisions. The Company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The Company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent the three sectors in which this Company aims to do business. Golden Triangle Ventures is highly focused on acquiring a well-diversified portfolio of companies under one umbrella, which are all managed and owned by the Company. An amazing team of professionals support each division and continue to help the Company grow daily. Being a publicly traded Company gives the ability to provide the support needed to help each subsidiary grow into the business that management believes it can and will become.
Golden Triangle Ventures’ business model is supported by the drive for vertical integration to cut costs and maximize margins. Management strives to acquire entities and assets that they fully understand, which maintain the prospect for long-term exponential growth. The mission is to provide the necessary resources for each subsidiary to generate profit, and then allow them to leverage each other and maximize economic impact. In addition, GTV provides a professional corporate representation service to different companies in these sectors while consulting on a variety of different business development objectives.
The backbone of this business is truly a team of professional advisors looking to help companies with a multitude of corporate objectives. With an extensive Rolodex of relationships, management can help with a dynamic range of project obstacles while maintaining a quality service for each client the Company represents. No matter what the needs are, the team involved can help facilitate many different transactions successfully for all parties involved. The network of relationships expands to industry experts who can assist with project management, product sourcing, industrial agriculture project implementation and so much more. Golden Triangle Ventures develops strategies and detailed plans that are custom-tailored to each corporate need and objective in all areas of business.
The GTV business model is focused on the following core group of interests:
Acquisitions / Assets / Holdings - The Company currently owns a unique portfolio of companies that are all being developed and supported by GTV, each holding a common goal of making a positive impact in the industry in which they operate.
Services - Services are deployed through Golden Triangle Ventures to assist all the unique opportunities within its operation. The Company also offers its services to select opportunities that could develop synergistic value within the relationship between both companies through the result of its efforts.
Investments - Management identifies high-value opportunities and provides capital investments in several companies and projects being developed. Each investment is complemented by a hands-on approach of helping to develop the overall direction and strategic plan for each opportunity.
For more information, visit us at: http://www.GoldenTriangleInc.com
About Lavish Entertainment, Inc.
Lavish Entertainment, Inc. is a wholly owned subsidiary of Golden Triangle Ventures operating under its Entertainment Division. Currently conducting its business out of Las Vegas, Nevada, the Company started doing business in 2017 and was established with a vision of becoming nationally recognized in concert production. The Company currently has more than 30,000 national followers and nearly 100 team members who have helped Lavish successfully organize some of the most exciting electronic dance music concerts in Las Vegas. Lavish Entertainment strives to produce high-quality and professional events that provide an immersive experience through state-of-the-art production and sound implementation.
Lavish Entertainment is currently developing a flagship entertainment complex called Destino Ranch, which intends to become an ideal outdoor music and festival venue, immersive art installation, tourist attraction and world-renowned destination center. The Company recently secured a purchase agreement to acquire nearly 70 acres of prime and improved land for its Destino Ranch project, which is strategically located in Arizona. The property has upgrades that represent a substantial investment totaling nearly $6 million, which has turned this once vacant land into a beautiful oasis that provides the initial infrastructure needed to begin the development of Destino Ranch.
Lavish Entertainment has completed a full acquisition of ABI Create (or “ABI”), a premier event management and production firm, which is managing the development of its Destino Ranch project. Founded in 2015 by Marco Antonio Moreno (recently appointed as the new president and COO of Lavish Entertainment), ABI Create has delivered high-quality productions for a range of large-scale installations at major music festivals, sporting events and conventions across the United States. Notable projects include collaborations with the NFL Super Bowl, San Diego and New York Comic Con, EDC and Camp EDC, Bonnaroo Music Festival, the Waste Management Phoenix Open, Arnold Palmer Invitational, Burning Man, and many more.
Forward-Looking Statements
Certain information set forth in this press release contains "forward-looking information," including "future-oriented financial information" and "financial outlook," under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company's business, projects and joint ventures; (iv) execution of the Company's vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company's projects; (vi) completion of the Company's projects that are currently underway, in development or otherwise under consideration; (vii) renewal of the Company's current customer, supplier and other material agreements; and (viii) future liquidity, working capital and capital requirements. Forward-looking statements are provided to give potential investors the opportunity to understand management's beliefs and opinions in respect to the future so they may use such beliefs and opinions as one factor in evaluating an investment. These statements are not guarantees of future performance, and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change, except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements. The Securities and Exchange Commission ("SEC") has provided guidance to issuers regarding the use of social media to disclose material nonpublic information. In this regard, investors and others should note that we announce material financial information on our Company website, www.GoldenTriangleInc.com, in addition to SEC filings, press releases, public conference calls and webcasts. We also use social media to communicate with the public about our Company, our services and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, in light of the SEC's guidance, we encourage investors, the media and others interested in our Company to review the information we post on the following U.S. social media channels:
X: https://x.com/GTV_Inc
CONTACT INFORMATION:
Golden Triangle Ventures, Inc.
info@GoldenTriangleInc.com
Corporate Communications
IBN
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
$GV News: GV Announces Tokenization Partnership with ABB-FG
TORONTO, June 6, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced on June 5, 2024 Visionary Holding Group's CEO, Mr. Zhong Chen, and Simon Tang, Director of ABB-FG (American Business Brokerage & Funding Grp) from the United States, signed a Tokenization Partnership Agreement. Parties wish to form a Partnership to develop the business of tokenization and securitization of Real-World Assets ("RWA") in Canada.
ABB-FG will use cutting-edge digital technology and specialized securitization laws to register various real-world assets (RWA) with the U.S. Securities and Exchange Commission under Reg. D/S/A+. These assets will be supported by the most reliable public blockchain and token platforms and will be listed for uninterrupted trading on major global digital asset exchanges (ATS). After digitizing and securitizing the properties at 95-105 Moatfield Dr, ABB-FG will facilitate their global trading on ATS, significantly enhancing the value of these properties. This will also rapidly boost Visionary's own economic growth, advancing Visionary's industries toward internet-based, digital, and intelligent operations. The transformation will reduce operational costs, improve user experience, and increase industry revenue, positioning Visionary as a pioneer in Canada's digital economy.
About Visionary Holdings Inc.
Visionary Holdings Inc. headquartered in Toronto, Canada, a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China. The Company aims to provide access to secondary, college, undergraduate and graduate and vocational education to students in Canada through technological innovation so that more people can learn, grow and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the Company has been serving and will continue to serve both Canadian and international students. For more information, visit the Company's website at https://ir.visiongroupca.com/.
Forward-Looking Statements
All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "believes," "expects," "anticipates," "estimates," "intends," "would," "continue," "should," "may," or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and in its other filings with the SEC.
For more information, please contact:
Visionary Holdings Inc.
Investor Relations Department
Email: ir@farvision.ca
View original content:https://www.prnewswire.com/news-releases/gv-announces-tokenization-partnership-with-abb-fg-302166110.html
SOURCE Visionary Holdings Inc.
$CRDL stock gave me a good opportunity to buy at a lower price yesterday. Now my average is $2.35. The chart is still very positive, and it’s just a matter of time; it could hit $3.50–3.75 very soon (technical breakout).
I have a strong feeling that we will get a positive outcome from the FDA for the company’s Phase II MAvERIC-Pilot study for CardiolRx (DUE IN JUNE). If we get this, then the sky is the limit and we may hit a double digit.
Followers
|
525
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
45886
|
Created
|
02/21/10
|
Type
|
Free
|
Moderator MaxPowerLove$Ihub | |||
Assistants mick Ask$lapper k124Inv RoadRunner3 |
Welcome!
Sad =( Not Funny! But it's True!
Remember, The OTC Market is like Vegas! Treat trading & investing in every penny stocks like Casino gambling!
Check out some of our picks & results in the past:
Recent Plays:
Le2dynasty: Alerted for CBYI in late March @ the point when the stock was at no bid. A few weeks later the PPS reached .0004s (400% gain)
Le2dynasty: Alerted for GRPS (together with KGRI, CBYI) @ .0001s on May 17th...On May 23rd the PPS touched .0012s (1,200% gain)
Le2dynasty: Alerted for CBYI @ .0001s on May 23rd -- early morning & within a few hours, the PPS reached .0003s with mega trading volume-- (71 mil. total trading vol. with 99% buyin' vol.) (300% gain)
Le2dynasty: Alerted for CBYI @ .0002s on May 24rd -- early morning & immediately, the PPS reached .0004s with mega trading volume -- (more than 100 mil. total trading vol. CBYI was the top in top trading vol. on this day) (100% gain)
Le2dynasty: Alerted for EMLL @ .0002s on July 2nd -- early morning & the PPS reached .0004s with mega trading volume -- (more than 260 mil. total trading vol. EMLL became the top in top trading vol. & top in breakout board on this day) (50% gain)
Le2dynasty: Alerted for HIRU @ .0001s on July 3rd & on July 9, HIRU reached .0006s with mega trading volume (600% gain)
Le2dynasty: Alerted for IMDS @.0005s on July 9 @ the pt. when the total trading vol. is below 80 mil. Within 50 minutes later, the PPS reached .0009s, with more than 245 mil. total trading vol. (80% gain) in less than 1 hr. On July 10th another alert was sent out to remind traders/investors & on July 12th, the PPS reached .0026s..that is more than (500% gain) since July 9 alert.
Le2dynasty: Alerted for NVAE in early moring @ the pt. when the stock was @ no bid. PPS then reached .0003s (200% again) with a mega trading vol. (end the trading day with more than 230 mil total trading vol.). Unfortunately, the the stock dropped back to .0001 at closing.
BurntOrang3: : 400-500% gains off of DRGI after the alert
BurntOrang3: : Over 100% gains after my AUCI alert
**** Attention: Mods, Please don't edit the ibox w/o asking me first, b/c there are some kind of coding problems here ...and the IH Greeks ...Especially IH Greek (Dave) had spent a lot of time fixing this. Thank you Dave and thank all the mods here as well ****
Our Associates:
TheKingPennyStock
Daily 000X Plays
Monster Day Traders
Pinky With Potential!
BOTTOM PLAYS! CHART TECH! RESEARCH! STRATEGIES!
"A Dawgg"
Billionaire Boys Club Member Forum (BBCMF)
THE WALL STREET CLUB
$THE WAVE
THE BLUE EXCHANGE
ALERTS, CHARTS, & HOT STOCKS
Momentum Players
Momentum Runners
MOMO'S BREAKOUT BOARD
STOCKGOODIES PLAYS OF THE WEEK
Welcome To The Zoo
~~~TEFFY''S~~~HOT~~~PROFILED~~~PICKS~~~
Another Winning Trade
CASH COW
EZ Traders Forum
NO BRAINERS
StocksDiva Bio Bin
Pinto Beans and Money Making Stock Picks
PINKSHEET Breakout Board!!!
Picks For Every Play
Penny Stock Millionaire
The Van Scan
UNDERVALUED PENNY STOCKS
The Penny Stock Grow Room
Wowza board
Disclaimer: We are not investment advisors. We recommend investors to do their own due diligence. Never invest in any stock unless you can afford to lose your entire investment. Opinions expressed on this board are only opinions.
PER IHUB MGMT |
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Posts Today
|
0
|
Posts (Total)
|
45886
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |